A detailed history of Sherbrooke Park Advisers LLC transactions in Embecta Corp. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 20,600 shares of EMBC stock, worth $426,420. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,600
Previous 35,911 42.64%
Holding current value
$426,420
Previous $449 Million 35.29%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.46 - $16.56 $175,464 - $253,550
-15,311 Reduced 42.64%
20,600 $290 Million
Q2 2024

Aug 14, 2024

BUY
$10.13 - $14.6 $363,778 - $524,300
35,911 New
35,911 $449 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.2B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.